EXPERIMENTAL CELL RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-11-24 ms4000001001813942 来自重庆

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：纤维化
经验分享：请教一下各位，怎么在接收后更改自己的publishing option？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-05-04 ms4000000515861732

审稿速度:24.0 | 投稿命中率:5.0
偏重的研究方向：肿瘤
经验分享：感觉要被坑死了

50 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2023-01-11 ms2000000115605427 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。

39 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-12-09 ms7000000536219893 来自甘肃省

投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？

50 0

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2018-09-05 1201e806m45(暂无昵称)

我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表::
想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表:
想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief

yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief

198 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2021-09-03 145fe683m03暂无昵称

友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。

65 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-10-19 032303145

审稿速度:3.0 | 投稿命中率:50.0
经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！

49 0

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-02-14 1227ee37m70暂无昵称

偏重的研究方向：细胞分化;siRNA
经验分享：刚投，🙏

60 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-03-18 ms5000001080341430

请问with editor一般要多久啊，9天了都没变过

42 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2102496, encodeId=5442210249639, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纤维化 经验分享：请教一下各位，怎么在接收后更改自己的publishing option？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6a46395902, createdName=ms4000001001813942, createdTime=Thu Nov 24 21:56:18 CST 2022, time=2022-11-24, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=1216797, encodeId=9d831216e9775, content=审稿速度:24.0 | 投稿命中率:5.0 偏重的研究方向：肿瘤 经验分享：感觉要被坑死了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7d65597774, createdName=ms4000000515861732, createdTime=Wed May 04 15:38:27 CST 2022, time=2022-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2109815, encodeId=cdf32109815fd, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2022-07-10提交，2022-11-14接收。外审三个月，一直找不到第二个审稿人。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=299f5555136, createdName=ms2000000115605427, createdTime=Wed Jan 11 13:24:29 CST 2023, time=2023-01-11, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2105095, encodeId=f6612105095d5, content=投稿综述要先跟主编联系吗？为什么没有给主编的邮箱啊？有人知道吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b216539211, createdName=ms7000000536219893, createdTime=Fri Dec 09 16:29:33 CST 2022, time=2022-12-09, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=560729, encodeId=6525560e2963, content=我的不是约稿，可以直接给编辑写信yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chiefyulze 2018-08-14 00:00:00 发表: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved buy editor in chief, beContent=yulze 2018-08-14 发表:: 想问一下，综述只接受约稿吗？do not accept unsolicited review articles unless they are preapproved *** editor in chief, objectType=tool_impact_factor, channel=null, level=null, likeNumber=198, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201106/8ab12f5eaf834b4ba11618afc4d31d40/f9af7e1195ec44d6a61e5461616475d3.jpg, createdBy=020b2155424, createdName=1201e806m45(暂无昵称), createdTime=Wed Sep 05 00:00:00 CST 2018, time=2018-09-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1014410, encodeId=f2581014410e3, content=友友们，有人知道这个杂志编辑部的邮箱吗，我有一个作者的邮箱写错了，收不到确认邮件📧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=65, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210903/369d1ad7a43f48b99922bf7eaee8aec1/fd1dbdb484ac4e8f8d6f1d509a1fb247.jpg, createdBy=47775104082, createdName=145fe683m03暂无昵称, createdTime=Fri Sep 03 22:45:38 CST 2021, time=2021-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094718, encodeId=d4db2094e18af, content=审稿速度:3.0 | 投稿命中率:50.0 经验分享：2021.10.07提交，10.11under review，12.31返回修改意见，一共两个审稿人，都挺中肯的，2022.1.27修回，1.28接收。Good luck！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=986e36421, createdName=032303145, createdTime=Wed Oct 19 14:20:17 CST 2022, time=2022-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193340, encodeId=c5031193340aa, content=偏重的研究方向：细胞分化;siRNA 经验分享：刚投，🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f2892336301, createdName=1227ee37m70暂无昵称, createdTime=Mon Feb 14 16:49:29 CST 2022, time=2022-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1203686, encodeId=827512036864f, content=请问with editor一般要多久啊，9天了都没变过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=31286456069, createdName=ms5000001080341430, createdTime=Fri Mar 18 08:14:47 CST 2022, time=2022-03-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1219557, encodeId=e25f121955ec2, content=大家的返修之后多久会有消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=38, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/1LjAHepS0g8X8uPoticBYSmddOwquT3wcfbZpIHuMUXoWfVASuwmpeib0cxY6N7BC0FIvJ9RPe6y92nmxauqrToQ/132, createdBy=306c2478464, createdName=HLP-Helen, createdTime=Sat May 14 12:54:53 CST 2022, time=2022-05-14, status=1, ipAttribution=)]

2022-05-14 HLP-Helen

大家的返修之后多久会有消息呀

38 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务